Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.

التفاصيل البيبلوغرافية
العنوان: Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
المؤلفون: Goodwin, Pamela J, Chen, Bingshu E, Gelmon, Karen A, Whelan, Timothy J, Ennis, Marguerite, Lemieux, Julie, Ligibel, Jennifer A, Hershman, Dawn L, Mayer, Ingrid A, Hobday, Timothy J, Bliss, Judith M, Rastogi, Priya, Rabaglio-Poretti, Manuela, Mukherjee, Som D, Mackey, John R, Abramson, Vandana G, Oja, Conrad, Wesolowski, Robert, Thompson, Alastair M, Rea, Daniel W, Stos, Paul M, Shepherd, Lois E, Stambolic, Vuk, Parulekar, Wendy R
المصدر: JAMA ; ISSN:1538-3598 ; Volume:327 ; Issue:20
بيانات النشر: Silverchair Information Systems
سنة النشر: 2022
المجموعة: PubMed Central (PMC)
الوصف: Metformin, a biguanide commonly used to treat type 2 diabetes, has been associated with potential beneficial effects across breast cancer subtypes in observational and preclinical studies.
نوع الوثيقة: report
article in journal/newspaper
اللغة: English
العلاقة: https://doi.org/10.1001/jama.2022.6147Test; https://pubmed.ncbi.nlm.nih.gov/35608580Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131745Test/
DOI: 10.1001/jama.2022.6147
الإتاحة: https://doi.org/10.1001/jama.2022.6147Test
https://pubmed.ncbi.nlm.nih.gov/35608580Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131745Test/
رقم الانضمام: edsbas.4059C651
قاعدة البيانات: BASE